349 related articles for article (PubMed ID: 18936316)
1. Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study.
Marks MP; Olivot JM; Kemp S; Lansberg MG; Bammer R; Wechsler LR; Albers GW; Thijs V;
Radiology; 2008 Nov; 249(2):614-23. PubMed ID: 18936316
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
[TBL] [Abstract][Full Text] [Related]
3. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
[TBL] [Abstract][Full Text] [Related]
4. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke.
Nakashima T; Toyoda K; Koga M; Matsuoka H; Nagatsuka K; Takada T; Naritomi H; Minematsu K
Int J Stroke; 2009 Dec; 4(6):425-31. PubMed ID: 19930051
[TBL] [Abstract][Full Text] [Related]
5. Fluid-Attenuated Inversion Recovery Vascular Hyperintensities-Diffusion-Weighted Imaging Mismatch Identifies Acute Stroke Patients Most Likely to Benefit From Recanalization.
Legrand L; Tisserand M; Turc G; Edjlali M; Calvet D; Trystram D; Roca P; Naggara O; Mas JL; Méder JF; Baron JC; Oppenheim C
Stroke; 2016 Feb; 47(2):424-7. PubMed ID: 26732567
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
[TBL] [Abstract][Full Text] [Related]
7. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator.
Linfante I; Llinas RH; Selim M; Chaves C; Kumar S; Parker RA; Caplan LR; Schlaug G
Stroke; 2002 Aug; 33(8):2066-71. PubMed ID: 12154264
[TBL] [Abstract][Full Text] [Related]
8. Is the Susceptibility Vessel Sign on 3-Tesla Magnetic Resonance T2*-Weighted Imaging a Useful Tool to Predict Recanalization in Intravenous Tissue Plasminogen Activator?
Yamamoto N; Satomi J; Harada M; Izumi Y; Nagahiro S; Kaji R
Clin Neuroradiol; 2016 Sep; 26(3):317-23. PubMed ID: 25516146
[TBL] [Abstract][Full Text] [Related]
9. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
[TBL] [Abstract][Full Text] [Related]
10. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials.
Thomalla G; Schwark C; Sobesky J; Bluhmki E; Fiebach JB; Fiehler J; Zaro Weber O; Kucinski T; Juettler E; Ringleb PA; Zeumer H; Weiller C; Hacke W; Schellinger PD; Röther J;
Stroke; 2006 Mar; 37(3):852-8. PubMed ID: 16439696
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours.
Röther J; Schellinger PD; Gass A; Siebler M; Villringer A; Fiebach JB; Fiehler J; Jansen O; Kucinski T; Schoder V; Szabo K; Junge-Hülsing GJ; Hennerici M; Zeumer H; Sartor K; Weiller C; Hacke W;
Stroke; 2002 Oct; 33(10):2438-45. PubMed ID: 12364735
[TBL] [Abstract][Full Text] [Related]
12. Does Diffusion Lesion Volume Above 70 mL Preclude Favorable Outcome Despite Post-Thrombolysis Recanalization?
Tisserand M; Turc G; Charron S; Legrand L; Edjlali M; Seners P; Roca P; Lion S; Naggara O; Mas JL; Méder JF; Baron JC; Oppenheim C
Stroke; 2016 Apr; 47(4):1005-11. PubMed ID: 26979862
[TBL] [Abstract][Full Text] [Related]
13. Clinical and MRI predictors of no early recanalization within 1 hour after tissue-type plasminogen activator administration.
Kimura K; Sakamoto Y; Aoki J; Iguchi Y; Shibazaki K; Inoue T
Stroke; 2011 Nov; 42(11):3150-5. PubMed ID: 21868738
[TBL] [Abstract][Full Text] [Related]
14. Microplasmin and tissue plasminogen activator: comparison of therapeutic effects in rat stroke model at multiparametric MR imaging.
Chen F; Suzuki Y; Nagai N; Sun X; Wang H; Yu J; Marchal G; Ni Y
Radiology; 2007 Aug; 244(2):429-38. PubMed ID: 17581889
[TBL] [Abstract][Full Text] [Related]
15. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
16. Importance of cerebral artery recanalization in patients with stroke with and without neurological improvement after intravenous thrombolysis.
Kharitonova TV; Melo TP; Andersen G; Egido JA; Castillo J; Wahlgren N;
Stroke; 2013 Sep; 44(9):2513-8. PubMed ID: 23881960
[TBL] [Abstract][Full Text] [Related]
17. Early ischaemic diffusion lesion reduction in patients treated with intravenous tissue plasminogen activator: infrequent, but significantly associated with recanalization.
Sakamoto Y; Kimura K; Shibazaki K; Inoue T; Uemura J; Aoki J; Sakai K; Iguchi Y
Int J Stroke; 2013 Jul; 8(5):321-6. PubMed ID: 23013151
[TBL] [Abstract][Full Text] [Related]
18. Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator.
Nighoghossian N; Hermier M; Adeleine P; Derex L; Dugor JF; Philippeau F; Ylmaz H; Honnorat J; Dardel P; Berthezène Y; Froment JC; Trouillas P
Stroke; 2003 Feb; 34(2):458-63. PubMed ID: 12574560
[TBL] [Abstract][Full Text] [Related]
19. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study.
Neumann-Haefelin T; du Mesnil de Rochemont R; Fiebach JB; Gass A; Nolte C; Kucinski T; Rother J; Siebler M; Singer OC; Szabo K; Villringer A; Schellinger PD;
Stroke; 2004 Jan; 35(1):109-14. PubMed ID: 14671246
[TBL] [Abstract][Full Text] [Related]
20. Effects of 0.6 mg/kg intravenous alteplase on vascular and clinical outcomes in middle cerebral artery occlusion: Japan Alteplase Clinical Trial II (J-ACT II).
Mori E; Minematsu K; Nakagawara J; Yamaguchi T; Sasaki M; Hirano T;
Stroke; 2010 Mar; 41(3):461-5. PubMed ID: 20075341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
